The company is not selling any securities under this prospectus and will not receive any proceeds from the sale of its common stock by the selling stockholder.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDT:
- Conduit Pharmaceuticals receives further patent approval for AZD1656
- Conduit Pharmaceuticals Announces Leadership Changes and Bylaws Update
- Conduit Pharmaceuticals announces new addition to autoimmune pipeline
- Conduit Pharmaceuticals Secures Funding and Modifies Debt Agreements
- Conduit Pharmaceuticals files $100M mixed securities shelf